Six protein array assay schemes and three different labels (Au, carbon, enzyme) were evaluated to identify the most sensitive colorimetric assay scheme to be exploited in an on-chip immunoassay for IL8, DCN, and VEGF, three protein markers that have been previously demonstrated to be important for the detection of bladder cancer recurrence. Here, DCN is linked to urinary bladder carcinoma.